TVM Capital Healthcare appoints senior advisor

John Brooks, former chief executive of Joslin Diabetes Center, will help to identify new investment opportunities.

TVM Capital Healthcare Partners, the Dubai-based unit of TVM Capital, has appointed John Brooks as a senior advisor.

The appointment of Brooks, an expert in the healthcare industry, medical technology and treatment of diabetes, signals the firm’s desire to invest in areas where demand is growing for highly specialist care, it said.

Brooks, formerly president and chief executive of Boston-based Joslin Diabetes Center, will work alongside the firm’s investment and operations teams to identify new investment opportunities.

Brooks currently serves as chairman of the board for several healthcare organisations, including mobile diabetes management system Cellnovo Group; diabetes-focused non-profit College Diabetes Network; and Thermalin Diabetes, a company focused on insulin technology. He is also a board member of Hygieia, a healthcare company specialising in insulin guidance systems, and Ammonett Pharma, a privately owned biotech company.

“John brings with him a vast level of experience in cutting-edge diabetes research and treatment, as well as the sharp business acumen needed to spot investment opportunities in the emerging market’s burgeoning healthcare and medtech industry,” TVM Capital Healthcare founding partner Hoda Abou-Jamra said.

TVM Capital Healthcare is currently in market with its third fund, targeting $300 million, which will look to invest in up to 12 healthcare companies in the Middle East and North Africa, India, and south-east Asia, focusing on growth capital investments, as reported by Private Equity International.

The vehicle follows the $50 million TVM Healthcare MENA I fund launched in 2009, which, with co-investments, had the capacity to invest $90 million. That fund is fully invested in five deals across the Middle East, North Africa and India.

Fund III will follow the same strategy as its predecessor, pursuing growth investments and buyouts in companies that are or have the potential to become regional leaders in the healthcare market, according to its website. The firm’s model is to bring Western healthcare service providers, operators and products to its target region, according to its website.